- The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα…
March 15, 2025 11:25 ET | Source: ZENTALIS PHARMACEUTICALS Azenosertib median duration of response (mDOR) updated to 6.3 months in…
TALLMADGE, Ohio, March 15, 2025 (GLOBE NEWSWIRE) -- In 2025, the landscape of oral health is transforming, and at the…
-- No Shareholder Action Required at This Time -- PARSIPPANY, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc.…
TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone”…
March 14, 2025 18:15 ET | Source: Cannabix Technologies Inc. VANCOUVER, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) -- Cannabix…
Accessibility: Skip TopNav March 14, 2025 16:31 ET | Source: Oculis Holding AG ZUG, Switzerland, March 14, 2025 (GLOBE NEWSWIRE)…
March 14, 2025 16:30 ET | Source: Trinity Biotech plc DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc…
TORONTO, March 14, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF)…
KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare…